WHX 2026: Burjeel’s Dr Shamsheer Vayalil on building a global hub for complex care
The chairman and CEO – Burjeel Holdings, outlines how healthcare in the region is shifting from treating illness to managing wellness and longevity
10 February, 2026
TT
16
In 2025, Burjeel marked milestones from pioneering AI-powered dentistry to performing the country’s youngest infant liver transplant, while expanding complex care networks and advancing medical research.
In this interview with Gulf Business, Dr Shamsheer Vayalil, chairman and CEO, Burjeel Holdings, envisions a shift from treating illness to managing wellness and longevity, with AI, remote monitoring, and multidisciplinary expertise reshaping patient expectations and care delivery across the region.
How do you assess the healthcare landscape in 2025, and what key shifts do you anticipate as the sector moves into 2026?
The year 2025 saw healthcare accelerating digital adoption and embracing artificial intelligence for enhanced diagnostics, operations and patient care. From electronic medical records (EMR) and robotic surgeries to AI models for patient interaction, both caregivers and patients benefited from this evolution. While technology allowed clinicians to spend more time with patients and democratised care beyond borders, it also empowered patients with valuable information. Personalised and precision care became more prevalent. There were breakthroughs in complex care, mental health, remote care and medical research.
As we move into 2026, I believe healthcare will move from the concept of sickness to wellness and longevity because chronic and lifestyle diseases are increasing and require continuous management. Care will be delivered through systems, not just through individual brilliance. The focus will shift from volume to value, from hospital-only care to extended care, and from intuition-only to insight-supported care. The care journey will become more connected, with AI-assisted tools supporting decision-making and reducing variation.
Which treatments and medical innovations are expected to gain the most traction in 2026, and what will drive their adoption?
A set of advanced and technology-driven therapies is expected to gain major traction in 2026. As mentioned earlier, AI-powered diagnostics will expand rapidly as healthcare institutions adopt tools that speed up imaging analysis and improve triage. Complex care, including oncology, cardiology, neurology, and transplants, will continue to remain a focal point, with innovation as the anchor. Precision medicine and cell and gene therapies will continue to grow as genetic insights play a crucial role throughout the patient journey.
At the same time, remote monitoring and home-based treatment will become more common as patients look for convenience and health systems work to manage chronic diseases more proactively. Mental health digital therapeutics will also gain traction as people seek accessible, tech-enabled support. Altogether, these trends signal a clear shift toward healthcare that is more personalised, predictive, and connected than what we have seen before.
How are patient expectations evolving across the region, and how is this influencing the way healthcare providers design and deliver care?
Patients no longer see healthcare as a series of isolated appointments. They want continuity, coordination, and systems that understand them at every interaction, regardless of speciality, facility, or stage of care. This is where integrated care models and platform-based thinking, where information, expertise, and workflows flow smoothly across the system rather than sitting in one department, become significant. Individual clinical excellence still matters, but it must translate into coordinated, empathetic, and consistent care that feels unified from start to finish.
It is time for healthcare institutions to rethink everything from digital infrastructure to care pathways to ensure they can deliver experiences that are not only clinically strong but also connected, human and outcome-driven.
What were the most significant operational or clinical milestones for Burjeel in 2025, and what key lessons will shape your priorities for the year ahead?
The year marked scale and responsibility for us. Burjeel achieved several operational and clinical milestones, including performing the UAE’s youngest infant liver transplant, advancing diabetes research in space, becoming a regional model for managing rare and inherited diseases, expanding robotic surgery programmes, and implementing a smart, future-ready EMR platform to strengthen workflows and care coordination.
We also extended our cancer care network into new geographies, introduced robotics and AI-powered dentistry to the UAE, and expanded our medical education programmes to nurture the next generation of healthcare professionals.
Going forward, we remain focused on scaling with substance, strengthening complex care specialities, and expanding selectively with clear ROI gates.
How do partnerships support Burjeel’s long-term vision and strengthen its regional leadership?
Partnerships enable us to take care beyond borders, bring world-class care to the UAE, and reach communities faster. By collaborating with global centres of excellence, research institutions, and technology leaders, we can introduce new capabilities, strengthen our complex care programmes, expand access to advanced diagnostics and therapeutics, and create avenues for knowledge exchange. All of this helps raise clinical standards across the region. Partnerships also support our commitment to talent development by opening doors for training, fellowships, and joint academic programmes that build a stronger, future-ready workforce.
Which specialties are emerging as key growth drivers in 2026?
Complex care specialties such as oncology, rare and inherited diseases, and cardiology will continue to be major growth drivers as we move into 2026. They will be supported by rising demand for advanced diagnostics, precision therapeutics, and multidisciplinary care. Pediatrics is another area gaining momentum, particularly in high-acuity care and complex interventions.
Our focus is on being a boutique of excellence, not a supermarket of services, and on contributing to broader economic growth. We are in a defining moment where we want to transform care delivery by prioritising depth, quality, and specialisation rather than breadth alone. The goal is to put the UAE on the global map as a hub for complex and highly specialised care.


















